Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
Post-market: 1.790.0300+1.70%19:55 EDT
Volume:133.33K
Turnover:233.60K
Market Cap:2.89M
PE:-0.15
High:1.82
Open:1.80
Low:1.71
Close:1.88
Loading ...
Jul 21, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 08, 2021

Major Issues Report

8-K - Current report
Jul 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 07, 2021

Major Issues Report

8-K - Current report
Jul 06, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 01, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 29, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 11, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 08, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 01, 2021

Business Combinations

425 - Prospectuses and communications, business combinations